Addex Historical Balance Sheet

ADXN Stock

USD 10.78 0.23 2.18%

Trend analysis of Addex Therapeutics balance sheet accounts such as Short Long Term Debt Total of 448 K, Other Current Liabilities of 1.3 M or Total Current Liabilities of 4 M provides information on Addex Therapeutics' total assets, liabilities, and equity, which is the actual value of Addex Therapeutics to its prevalent stockholders. By breaking down trends over time using Addex Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Addex Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Addex Therapeutics is a good buy for the upcoming year.

Addex Therapeutics Inventory

(745.22 Million)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

About Addex Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Addex Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Addex Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Addex Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Addex currently owns. An asset can also be divided into two categories, current and non-current.

Addex Therapeutics Balance Sheet Chart

At this time, Addex Therapeutics' Intangible Assets are very stable compared to the past year. As of the 11th of November 2024, Non Current Liabilities Total is likely to grow to about 761.6 K, while Total Assets are likely to drop about 4.4 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Cash Accumulated Amortization

Add Fundamental

Total Assets

Total assets refers to the total amount of Addex Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Addex Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Addex Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Addex Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash

Cash refers to the most liquid asset of Addex Therapeutics, which is listed under current asset account on Addex Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Addex Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Addex Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Accumulated Amortization

The cumulative amount of amortization expense charged against intangible assets, like patents and copyrights, over time.

Most accounts from Addex Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Addex Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.At this time, Addex Therapeutics' Intangible Assets are very stable compared to the past year. As of the 11th of November 2024, Non Current Liabilities Total is likely to grow to about 761.6 K, while Total Assets are likely to drop about 4.4 M.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	482.0K	373.1K	344.3K	448.0K
Total Assets	22.5M	8.3M	4.6M	4.4M

Short Long Term Debt Total Total Assets

Addex Therapeutics balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Non Current Liabilities Total	Net Receivables
Total Assets		-0.24	0.54	0.67	0.99	0.71	0.08	-0.99	0.57	0.58	0.99	0.54	0.08	0.99	-0.11	-0.34	-0.15	-0.43	0.66	0.25	1.0	0.06	-0.19	0.31	0.37	0.45
Short Long Term Debt Total	-0.24		0.08	-0.08	-0.27	-0.42	0.13	0.23	-0.43	-0.46	-0.23	-0.19	0.25	-0.23	-0.04	-0.23	-0.26	0.51	0.03	-0.64	-0.23	-0.28	0.01	0.38	0.34	-0.33
Other Current Liab	0.54	0.08		0.88	0.46	0.79	-0.25	-0.45	0.25	0.01	0.45	0.8	0.5	0.45	-0.27	-0.27	-0.04	-0.03	0.81	0.44	0.47	-0.15	-0.41	-0.1	0.27	0.65
Total Current Liabilities	0.67	-0.08	0.88		0.58	0.75	0.12	-0.61	0.17	0.42	0.61	0.66	0.26	0.61	0.07	-0.03	-0.01	-0.03	0.97	0.54	0.63	0.25	-0.13	0.09	0.55	0.51
Total Stockholder Equity	0.99	-0.27	0.46	0.58		0.67	0.05	-0.99	0.61	0.56	0.99	0.51	0.05	0.99	-0.14	-0.36	-0.16	-0.48	0.56	0.2	0.99	0.01	-0.2	0.3	0.29	0.43
Property Plant And Equipment Net	0.71	-0.42	0.79	0.75	0.67		-0.25	-0.63	0.7	0.22	0.62	0.9	0.38	0.62	-0.44	-0.39	-0.09	-0.57	0.64	0.5	0.64	-0.13	-0.52	-0.22	0.07	0.78
Current Deferred Revenue	0.08	0.13	-0.25	0.12	0.05	-0.25		-0.14	-0.28	0.5	0.15	-0.44	-0.55	0.15	0.55	0.27	-0.05	0.21	0.26	-0.2	0.14	0.66	0.65	0.45	0.63	-0.51
Net Debt	-0.99	0.23	-0.45	-0.61	-0.99	-0.63	-0.14		-0.53	-0.6	-1.0	-0.44	0.02	-1.0	0.04	0.3	0.16	0.4	-0.61	-0.2	-1.0	-0.09	0.11	-0.36	-0.37	-0.36
Retained Earnings	0.57	-0.43	0.25	0.17	0.61	0.7	-0.28	-0.53		0.14	0.53	0.64	0.29	0.53	-0.76	-0.74	-0.25	-0.92	0.07	-0.01	0.53	-0.41	-0.66	-0.17	-0.28	0.59
Accounts Payable	0.58	-0.46	0.01	0.42	0.56	0.22	0.5	-0.6	0.14		0.61	0.01	-0.31	0.61	0.42	0.18	0.13	-0.2	0.47	0.4	0.61	0.69	0.31	0.46	0.46	0.03
Cash	0.99	-0.23	0.45	0.61	0.99	0.62	0.15	-1.0	0.53	0.61		0.43	-0.03	1.0	-0.03	-0.29	-0.15	-0.4	0.61	0.21	1.0	0.11	-0.1	0.37	0.38	0.35
Non Current Assets Total	0.54	-0.19	0.8	0.66	0.51	0.9	-0.44	-0.44	0.64	0.01	0.43		0.75	0.43	-0.6	-0.5	-0.15	-0.49	0.55	0.33	0.45	-0.35	-0.73	-0.29	0.0	0.84
Non Currrent Assets Other	0.08	0.25	0.5	0.26	0.05	0.38	-0.55	0.02	0.29	-0.31	-0.03	0.75		-0.03	-0.59	-0.46	-0.16	-0.16	0.2	-0.05	-0.01	-0.53	-0.76	-0.27	-0.1	0.59
Cash And Short Term Investments	0.99	-0.23	0.45	0.61	0.99	0.62	0.15	-1.0	0.53	0.61	1.0	0.43	-0.03		-0.03	-0.29	-0.15	-0.4	0.61	0.21	1.0	0.11	-0.1	0.37	0.38	0.35
Common Stock Total Equity	-0.11	-0.04	-0.27	0.07	-0.14	-0.44	0.55	0.04	-0.76	0.42	-0.03	-0.6	-0.59	-0.03		0.87	0.25	0.64	0.17	0.29	-0.04	0.79	0.84	0.33	0.49	-0.54
Common Stock Shares Outstanding	-0.34	-0.23	-0.27	-0.03	-0.36	-0.39	0.27	0.3	-0.74	0.18	-0.29	-0.5	-0.46	-0.29	0.87		0.23	0.58	0.0	0.42	-0.3	0.61	0.71	-0.09	0.16	-0.41
Other Current Assets	-0.15	-0.26	-0.04	-0.01	-0.16	-0.09	-0.05	0.16	-0.25	0.13	-0.15	-0.15	-0.16	-0.15	0.25	0.23		0.32	-0.08	0.38	-0.15	0.31	0.2	-0.27	-0.27	0.14
Other Stockholder Equity	-0.43	0.51	-0.03	-0.03	-0.48	-0.57	0.21	0.4	-0.92	-0.2	-0.4	-0.49	-0.16	-0.4	0.64	0.58	0.32		0.05	0.02	-0.4	0.31	0.55	0.11	0.27	-0.47
Total Liab	0.66	0.03	0.81	0.97	0.56	0.64	0.26	-0.61	0.07	0.47	0.61	0.55	0.2	0.61	0.17	0.0	-0.08	0.05		0.46	0.63	0.36	-0.03	0.27	0.72	0.37
Property Plant And Equipment Gross	0.25	-0.64	0.44	0.54	0.2	0.5	-0.2	-0.2	-0.01	0.4	0.21	0.33	-0.05	0.21	0.29	0.42	0.38	0.02	0.46		0.22	0.43	0.1	-0.18	0.05	0.41
Total Current Assets	1.0	-0.23	0.47	0.63	0.99	0.64	0.14	-1.0	0.53	0.61	1.0	0.45	-0.01	1.0	-0.04	-0.3	-0.15	-0.4	0.63	0.22		0.1	-0.11	0.36	0.39	0.37
Short Term Debt	0.06	-0.28	-0.15	0.25	0.01	-0.13	0.66	-0.09	-0.41	0.69	0.11	-0.35	-0.53	0.11	0.79	0.61	0.31	0.31	0.36	0.43	0.1		0.58	0.37	0.59	-0.36
Intangible Assets	-0.19	0.01	-0.41	-0.13	-0.2	-0.52	0.65	0.11	-0.66	0.31	-0.1	-0.73	-0.76	-0.1	0.84	0.71	0.2	0.55	-0.03	0.1	-0.11	0.58		0.32	0.32	-0.59
Common Stock	0.31	0.38	-0.1	0.09	0.3	-0.22	0.45	-0.36	-0.17	0.46	0.37	-0.29	-0.27	0.37	0.33	-0.09	-0.27	0.11	0.27	-0.18	0.36	0.37	0.32		0.72	-0.38
Non Current Liabilities Total	0.37	0.34	0.27	0.55	0.29	0.07	0.63	-0.37	-0.28	0.46	0.38	0.0	-0.1	0.38	0.49	0.16	-0.27	0.27	0.72	0.05	0.39	0.59	0.32	0.72		-0.21
Net Receivables	0.45	-0.33	0.65	0.51	0.43	0.78	-0.51	-0.36	0.59	0.03	0.35	0.84	0.59	0.35	-0.54	-0.41	0.14	-0.47	0.37	0.41	0.37	-0.36	-0.59	-0.38	-0.21

Click cells to compare fundamentals

Addex Therapeutics Account Relationship Matchups

Addex Therapeutics balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.0M	20.2M	22.5M	8.3M	4.6M	4.4M
Other Current Liab	2.0M	1.5M	2.1M	1.7M	1.4M	1.3M
Total Current Liabilities	5.7M	3.6M	4.1M	3.3M	2.9M	4.0M
Total Stockholder Equity	25.5M	14.6M	16.9M	4.9M	1.1M	1.1M
Property Plant And Equipment Net	571.0K	633.1K	542.1K	398.7K	352.9K	335.3K
Current Deferred Revenue	212.7K	1.1M	820.1K	235.0K	270.2K	412.9K
Net Debt	(31.0M)	(18.1M)	(20.0M)	(6.6M)	(3.5M)	(3.7M)
Retained Earnings	(300.8M)	(313.7M)	(329.1M)	(349.9M)	(360.4M)	(378.4M)
Accounts Payable	2.2M	983.5K	1.8M	1.3M	984.4K	913.8K
Cash	31.5M	18.7M	20.5M	7.0M	3.9M	3.7M
Non Current Assets Total	639.9K	692.2K	600.0K	453.1K	407.3K	386.9K
Non Currrent Assets Other	68.9K	59.1K	57.9K	54.4K	54.3K	51.6K
Cash And Short Term Investments	31.6M	18.8M	20.5M	7.0M	3.9M	3.7M
Common Stock Shares Outstanding	26.4M	26.7M	34.1M	45.2M	74.3M	78.0M
Liabilities And Stockholders Equity	33.0M	20.2M	22.5M	8.3M	4.6M	4.4M
Other Current Assets	734.0K	498.4K	1.1M	871.9M	217.0K	206.2K
Other Stockholder Equity	286.4M	286.9M	272.3M	327.9M	329.9M	288.6M
Total Liab	7.5M	5.6M	5.6M	3.4M	3.5M	4.5M
Property Plant And Equipment Gross	571.0K	633.1K	4.3M	4.4M	4.7M	2.4M
Total Current Assets	32.4M	19.5M	21.9M	7.8M	4.2M	4.0M
Short Term Debt	373.0K	308.6K	287.7K	286.1K	274.0K	193.4K
Non Current Liabilities Total	1.8M	2.0M	1.5M	87.0K	603.1K	761.6K
Accumulated Other Comprehensive Income	7.1M	8.6M	24.4M	25.8M	29.8M	31.3M
Net Receivables	118.0K	68.4K	324.4K	598.3K	151.3K	271.7K
Other Liab	639.4K	1.6M	1.7M	1.3M	1.5M	813.2K
Net Tangible Assets	25.5M	14.6M	16.9M	4.9M	5.6M	5.4M
Other Assets	68.9K	59.1K	57.9K	54.4K	48.9K	66.0K
Short Term Investments	14.0K	64.9K	17.1K	3.2K	848.0	805.6
Property Plant Equipment	571.0K	633.1K	542.1K	398.7K	458.5K	275.1K
Net Invested Capital	25.5M	14.6M	16.9M	4.9M	1.1M	1.1M
Net Working Capital	26.7M	15.9M	17.8M	4.5M	1.3M	1.3M

Pair Trading with Addex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Addex Stock

0.62

DMAC

DiaMedica Therapeutics

Pair Corr

Moving against Addex Stock

0.66	DRMA	Dermata Therapeutics	Pair Corr
0.61	ME	23Andme Holding	Pair Corr
0.53	VALN	Valneva SE ADR	Pair Corr

The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.

The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:

How To Invest In Addex

Details

Is Addex Stock a good investment?

Details

What is Addex Therapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(19.18)

Revenue Per Share

1.2

Quarterly Revenue Growth

(0.82)

Return On Assets

(0.62)

Return On Equity

(1.26)

The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Addex Historical Balance Sheet

Addex Therapeutics Inventory

(745.22 Million)

About Addex Balance Sheet Analysis

Addex Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash

Accumulated Amortization

Addex Therapeutics balance sheet Correlations

Addex Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Addex Therapeutics balance sheet Accounts

Pair Trading with Addex Therapeutics

Moving together with Addex Stock

Moving against Addex Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Cash	+ 0.99	Total Assets

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Debt	- 0.99	Total Assets
Other Stockholder Equity	- 0.92	Retained Earnings